Meta-Analysis: The impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 5, 2013, Pages 460-466

  Abhyankar, A ^a   Ham, M ^a   Moss, A C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONCEPTION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; SYSTEMATIC REVIEW; ULCERATIVE COLITIS;

EID: 84882452332     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12417     Document Type: Article

References (33)

1. Beaulieu DB, Kane S,. Inflammatory bowel disease in pregnancy. World J Gastroenterol 2011; 17: 2696-701.
2. Mountifield R, Bampton P, Prosser R, Muller K, Andrews JM,. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009; 15: 720-5.
3. Abramson D, Jankelson IR, Milner LR,. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol 1951; 61: 121-9.
4. Castiglione F, Pignata S, Morace F, et al,. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996; 28: 199-204.
5. Nielsen OH, Andreasson B, Bondesen S, Jarnum S,. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-42.
6. Marri SR, Ahn C, Buchman AL,. Voluntary childlessness is increased in women with inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 591-9.
7. Riis L, Vind I, Politi P, et al,. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease Am J Gastroenterol 2006; 101: 1539-45.
8. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA,. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106-12.
9. Khosla R, Willoughby CP, Jewell DP,. Crohn's disease and pregnancy. Gut 1984; 25: 52-6.
10. Miller JP,. Inflammatory bowel disease in pregnancy: a review. J R Soc Med 1986; 79: 221-5.
11. Mogadam M, Korelitz BI, Ahmed SW, Dobbins WO III, Baiocco PJ,. The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 1981; 75: 265-9.
12. Vermeire S, Carbonnel F, Coulie PG, et al,. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis 2012; 6: 811-23.
13. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP,. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-41.
14. Balshem H, Helfand M, Schunemann HJ, et al,. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-6.
15. Stroup DF, Berlin JA, Morton SC, et al,. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
16. DerSimonian R, Laird N,. Meta-Analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
17. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-Analysis. Stat Med 2002; 21: 1539-58.
18. Egger M, Davey SG, Schneider M, Minder C,. Bias in meta-Analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
19. Cates CJ,. Simpson's paradox and calculation of number needed to treat from meta-Analysis. BMC Med Res Methodol 2002; 2: 1.
20. BANKS BM, Korelitz BI, Zetzel L,. The course of nonspecific ulcerative colitis: review of twenty years' experience and late results. Gastroenterology 1957; 32: 983-1012.
21. Bortoli A, Pedersen N, Duricova D, et al,. Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther 2011; 34: 724-34.
22. Crohn BB, Yarnis H, Crohn EB, Walter RI, Gabrilove LJ,. Ulcerative colitis and pregnancy. Gastroenterology 1956; 30: 391-403.
23. De Dombal FT, Watts JM, Watkinson G, Goligher JC,. Ulcerative colitis and pregnancy. Lancet 1965; 2: 599-602.
24. Homan WP, Thorbjarnarson B,. Crohn disease and pregnancy. Arch Surg 1976; 111: 545-7.
25. Macdougall I,. Ulcerative colitis and pregnancy. Lancet 1956; 271: 641-3.
26. McEwan HP,. Ulcerative colitis in pregnancy. Proc R Soc Med 1972; 65: 279-81.
27. Morales M, Berney T, Jenny A, Morel P, Extermann P,. Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000; 47: 1595-8.
28. Willoughby CP, Truelove SC,. Ulcerative colitis and pregnancy. Gut 1980; 21: 469-74.
29. Woolfson K, Cohen Z, McLeod RS,. Crohn's disease and pregnancy. Dis Colon Rectum 1990; 33: 869-73.
30. Julsgaard M, Norgaard M, Hvas CL, Buck D, Christensen LA,. Self-reported adherence to medical treatment prior to and during pregnancy among women with ulcerative colitis. Inflamm Bowel Dis 2011; 17: 1573-80.
31. Nielsen MJ, Norgaard M, Holland-Fisher P, Christensen LA,. Self-reported antenatal adherence to medical treatment among pregnant women with Crohn's disease. Aliment Pharmacol Ther 2010; 32: 49-58.
32. Kane S, Lemieux N,. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005; 100: 102-5.
33. Sheibani S, Mahadevan U,. Editorial: are thiopurines and anti-TNFalpha agents safe to use in pregnant patients with inflammatory bowel disease? Am J Gastroenterol 2013; 108: 441-3.